MCM
IMGN

Moore Capital Management’s Immunogen Inc IMGN Stock Holding History

Moore Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$297K – 577
2023
Q4 		$297K Sell
10,000
-67,916
-87% -$1.35M 0.01% 316
2023
Q3 		$1.24M Buy
+77,916
New +$1.3M 0.02% 280

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Moore Capital Management's IMGN Position: Q1 2024 in Review

Moore Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 10,000 shares — an estimated $297K sold.

Moore Capital Management first reported a position in IMGN in Q3 2023 and held it in 2 quarters. The position peaked at $1.24M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Moore Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Moore Capital Management sold 10,000 Immunogen Inc shares in Q1 2024, an estimated $297K.
  • Moore Capital Management first reported a position in Immunogen Inc in Q3 2023 and held it in 2 quarters.
  • Moore Capital Management's Immunogen Inc position peaked at $1.24M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Moore Capital Management's 13F filing for Q1 2024, filed 15 May 2024.